Table 1.
Substance | Experimental assay/Administration route | Animal tested | Dose | Activity |
---|---|---|---|---|
Chalcones | ||||
Butein
|
HCl/ethanol-induced ulcers/intragastric | Rat | 10 mg/kg | Active [65] |
NaOH-induced ulcers/intragastric | Rat | 50.0 mg/kg | Inactive [65] | |
2',3,4,4',6'-pentahydroxychalcone
|
HCl/ethanol-induced ulcers/intragastric | Rat | 10.0 mg/kg | Active [65] |
NaOH-induced ulcers/intragastric | Rat | 10.0 mg/kg | Active [65] | |
2',3,4-trihydroxychalcone
|
HCl/ethanol-induced ulcers/intragastric | Rat | 10.0 mg/kg | Active [65] |
NaOH-induced ulcers/intragastric | Rat | 10.0 mg/kg | Active [65] | |
2',4',6'-trihydroxychalcone
|
HCl/ethanol-induced ulcers/intragastric | Rat | 10.0 mg/kg | Active [65] |
NaOH-induced ulcers/intragastric | Rat | 10.0 mg/kg | Active [65] | |
2',4'-dihydroxy-3',5'-diprenyl-4-O-prenyl- chalcone
|
Stress-induced ulcers (water-immersion)/i.p. | Rat | 100.0 mg/kg | Active [42] |
2',4'-dihydroxy-3'-methoxychalcone
|
Ethanol-induced ulcers/intragastric | Mouse | * | Weak Active [66] |
Ethanol-induced ulcers/intragastric | Rat | 100.0 mg/kg | Active [67] | |
Ethanol-induced ulcers/intragastric | Rat | * | Active [66] | |
2',4'-dihydroxy-5'-prenyl-4-O-prenyl- chalcone
|
Pylorus ligation-induced ulcers/i.p. | Rat | 100.0 mg/kg | Active [42] |
Stress-induced ulcers (water-immersion)/i.p. | Rat | 100.0 mg/kg | Active [42] | |
2',4'-dihydroxychalcone
|
Stress-induced ulcers (water-immersion)/intragastric | Rat | 10.0 mg/kg | Active [65] |
Acetic acid-induced ulcers/intragastric | Rat | 10.0 mg/kg | Active [65] | |
HCl/ethanol-induced ulcers/intragastric | Rat | 10.0 mg/kg | Active [65] | |
NaOH-induced ulcers/intragastric | ||||
Ethanol-induced ulcers/intragastric | Rat | 10.0 mg/kg | Active [65] | |
Ethanol-induced ulcers/intragastric | Mouse | * | Active [66] | |
Ethanol-induced ulcers/intragastric | Rat | 100 mg/kg | Active [67] | |
Rat | * | Active [66] | ||
2',4,4',6'-tetrahydroxychalcone
|
HCl/ethanol-induced ulcers/intragastric | Rat | 10.0 mg/kg | Inactive [65] |
NaOH-induced ulcers/intragastric | Rat | 10.0 mg/kg | Active [65] | |
2',4,4'-trihydroxy-3,3',5'-tris-(3-methyl-but-2-enyl) chalcone
|
*/* | Rat | * | Active [68] |
2',4,4'-trihydroxy-3,3',5,5'-tetrakis-(3-methyl-but-2-enyl)-4,4'-bis-(O-3-methyl-but-2-enyl) chalcone
|
*/* | Rat | * | Active [69] |
2',4,4'-trihydroxy-3,3',5,5'-tetrakis-3-methyl-but-2-enyl) chalcone
|
*/* | Rat | * | Active [68] |
2',4,4'-trihydroxy-3,3',5-tris-(3-methyl-but-2-enyl)-4-4'-di-O-allyl chalcone
|
*/* | Rat | * | Active [69] |
2',4,4'-trihydroxy-3,3'-bis-(3-methylbut-2-enyl) chalcone
|
*/* | Rat | * | Active [68] |
2',4,4'-trihydroxy-3,3'-diprenylchalcone
|
Stress-induced ulcers (water-immersion)/i.p. | Rat | 100.0 mg/kg | Active [42] |
2',4,4'-trihydroxy-3,5,5'-tris-(3-methyl-but-2-enyl)-4'-O-(3-methylbut-2-enyl) chalcone
|
*/* | Rat | * | Active [69] |
2',4,4'-trihydroxychalcone
|
HCl/ethanol-induced ulcers/intragastric | Rat | 10.0 mg/kg | Active [65] |
NaOH-induced ulcers/intragastric | Rat | 10.0 mg/kg | Active [65] | |
2',4-dihydroxy-3-prenyl-4'-O-prenyl- chalcone
|
Stress-induced ulcers (water-immersion)/i.p. | Rat | 100.0 mg/kg | Active [42] |
2',4-dihydroxy-4'-methoxy-3-5-bis-(3-methyl-but-2-enyl) chalcone
|
*/* | Rat | * | Active [42] |
2'-carbomethoxy-4,4'-bis-(3-methyl-2-butenyl-oxy) chalcone (sofalcone)
|
Histamine-induced ulcers/i.p. | Rat | 100.0 mg/kg | Active [45] |
Acetic acid-induced ulcers/gastric intubation | Rat | 20-50 mg/kg | Active [45] | |
Histamine-induced ulcers/gastric intubation | Guinea pig | 100.0 mg/kg | Active [45] | |
Pylorus ligation-induced ulcers/i.p. | Rat | 50.0 mg/kg | Active [45] | |
Stress-induced ulcers (water-immersion)/i.p. | Rat | 50.0 mg/kg | Active [45] | |
Phenylbutazone-induced ulcers/gastric ntubation | Rat | 300.0 mg/kg | Active [45] | |
Acetic acid-induced ulcers/gastric intubation | Rat | 50.0 mg/kg | Active [44] | |
HCl induced gastric lesions/i.p. | Rat | 100.0 mg/kg | Active [46] | |
HCl induced gastric lesions/gastric intubation | Rat | 100.0 mg/kg | Active [46] | |
Pretreatment with indomethacin vs HCl induced gastric lesions/gastric intubation | Rat | 300.0 mg/kg | Active [46] | |
Pretreatment with indomethacin vs HCl induced gastric lesions/i.p. | Rat | 100.0 mg/kg | Active [46] | |
H. pylori induced ulcer/p.o. | Human adult | 100.0 mg/kg | Active [49] | |
2'-hydroxy-4,4'-di-O-prenylchalcone
|
Pylorus ligation-induced ulcers/i.p. | Rat | 100.0 mg/kg | Strong activity [42] |
Stress-induced ulcers (water-immersion)/i.p. | Rat | 100.0 mg/kg | Strong activity [42] | |
2,4'-di-O-prenylchalcone
|
Pylorus ligation-induced ulcers/i.p. | Rat | 100.0 mg/kg | Active [42] |
Stress-induced ulcers (water-immersion)/i.p. | Rat | 100.0 mg/kg | Weak activity [42] | |
2,4,4'-trihydroxy-3,3',5'-tris-(3-methyl-but-2-enyl)-4-O-allyl-4-O-propargyl-chalcone
|
*/* | Rat | * | Active [69] |
3',5'-dihydroxy-4'-prenyl-5-O-prenyl- chalcone
|
Pylorus ligation-induced ulcers/i.p. | Rat | 100.0 mg/kg | Strong activity [42] |
Stress-induced ulcers (water-immersion)/i.p. | Rat | 100.0 mg/kg | Strong activity [42] | |
3,3',4-trihydroxychalcone
|
HCl/ethanol-induced ulcers/intragastric | Rat | 10.0 mg/kg | Active [65] |
NaOH-induced ulcers/intragastric | Rat | 10.0 mg/kg | Active [65] | |
3,4,4'-trihydroxychalcone
|
HCl/ethanol-induced ulcers/intragastric | Rat | 10.0 mg/kg | Inactive [65] |
NaOH-induced ulcers/intragastric | Rat | 10.0 mg/kg | Active [65] | |
4'-hydroxy-3'-prenyl-4-O-prenylchalcone
|
Pylorus ligation-induced ulcers/i.p. | Rat | 100.0 mg/kg | Active [42] |
Stress-induced ulcers (water-immersion)/i.p. | Rat | 100.0 mg/kg | Strong activity [42] | |
4,4'-di-O-geranyl chalcone
|
Pylorus ligation-induced ulcers/i.p. | Rat | 100.0 mg/kg | Weak activity [42] |
Stress-induced ulcers (water-immersion)/i.p. | Rat | 100.0 mg/kg | Weak activity [42] | |
4,4'-di-O-prenylchalcone
|
Pylorus ligation-induced ulcers/i.p. | Rat | 100.0 mg/kg | Active [42] |
Stress-induced ulcers (water-immersion)/i.p. | Rat | 100.0 mg/kg | Strong activity [42] | |
4,4'-dihydroxy-3,3'-diprenylchalcone
|
Stress-induced ulcers (water-immersion)/i.p. | Rat | 100.0 mg/kg | Active [42] |
4,4'-dimethoxy-3,3'-diprenylchalcone
|
Pylorus ligation-induced ulcers/i.p. | Rat | 100.0 mg/kg | Weak activity [42] |
Stress-induced ulcers (water-immersion)/i.p. | Rat | 100.0 mg/kg | Active [42] | |
4-hydroxy-3-prenyl-4'-O-prenylchalcone
|
Pylorus ligation-induced ulcers/i.p. | Rat | 100.0 mg/kg | Active [42] |
Stress-induced ulcers (water-immersion)/i.p. | Rat | 100.0 mg/kg | Weak activity [42] | |
2',4-bis-(carbomethoxy)-4'-(3-carboxy-2-butenyl-oxy) dihydrochalcone
|
Pylorus ligation-induced ulcers/i.p. | Rat | 100.0 mg/kg | Weak activity [70] |
Stress-induced ulcers (water-immersion)/i.p. | Rat | 100.0 mg/kg | Weak activity [70] | |
Histamine-induced ulcers/i.p. | Rat | 100.0 mg/kg | Weak activity [70] | |
2',4-bis-(carboxymethoxy)-4'-(3-methyl-2-butenyl-oxy) dihydrochalcone
|
Pylorus ligation-induced ulcers/i.p. | Rat | 100.0 mg/kg | Active [70] |
Stress-induced ulcers (water-immersion)/i.p. | Rat | 100.0 mg/kg | Weak activity [70] | |
Histamine-induced ulcers/i.p. | Rat | 100.0 mg/kg | Active [70] | |
2'-carboxymethoxy-4-4'-bis-(3-methyl-2-butenyl-oxy) dihydro-chalcone
|
Pylorus ligation-induced ulcers/i.p. | Rat | 100.0 mg/kg | Active [70] |
Stress-induced ulcers (water-immersion)/i.p. | Rat | 100.0 mg/kg | Active [70] | |
Histamine-induced ulcers/i.p. | Rat | 100.0 mg/kg | Active [70] | |
Garcinol
|
Stress-induced (restraint) ulcers/intragastric | Rat | 200.0 mg/kg | Active [52] |
Indomethacin-induced ulcers/intragastric | Rat | 200.0 mg/kg | Active [52] | |
Sophoradin
|
Pylorus ligation-induced ulcers/p.o. | Rat | * | Active [43] |
Stress-induced ulcers/p.o. | Rat | * | Active [43] | |
Pylorus ligation-induced ulcers/p.o. | Rat | 100.0 mg/kg | Strong activity [42] | |
Stress-induced ulcers/p.o. | Rat | 100.0 mg/kg | Strong activity [42] | |
Xanthoangelol E
|
Stress-induced (restraint) ulcers/intragastric | Rat | 100.0 mg/kg | Active [71] |
Flavanones | ||||
3',4',5,7-tetrahydroxy-3-methoxy- flavanone
|
stress-induced (restraint) ulcers/* | Rat | * | Active [72] |
2',4',7-trihydroxy-5-methoxy-8-(5-hydroxy-5-methyl-2-iso-propenyl-hexyl) flavanone
|
*/p.o. | Human adult | * | Active [73] |
Hesperidin
|
Cold stress-induced ulcers/intragastric | Rat | 100.0 mg/kg | Active [74] |
Ethanol-induced ulcers/intragastric | Rat | 100.0 mg/kg | Inactive [74] | |
Naringenin
|
Acetic acid-induced ulcers/intragastric | Rat | 100.0 mg/kg | Active [62] |
Stress-induced ulcers (water-immersion)/intragastric | Rat | 100.0 mg/kg | Weak active [56] | |
Pylorus ligation-induced ulcers/intragastric | Rat | 100.0 mg/kg | Active [56] | |
Pylorus ligation-induced ulcers /intragastric | Rat | 100.0 mg/kg | Active [56] | |
Pylorus ligation-induced ulcers/gastric intubation | Rat | ED50 132 mg/kg | Active [75] | |
Stress-induced (restraint) ulcers/gastric intubation | Rat | ED50 42.0 mg/kg | Active [75] | |
Aspirin-induced ulcers/gastric intubation | Rat | * | Active [75] | |
Phenylbutazone-induced ulcers/gastric intubation | Rat | * | Active [75] | |
Reserpine-induced ulcers/gastric intubation | Rat | * | Active [75] | |
Naringin
|
Aspirin-induced ulcers/intragastric | Rat | 200.0 mg/kg | Active [76] |
Acid-ethanol-induced ulcers/i.p. | Rat | 100.0 mg/kg | Inactive [37] | |
Acid-ethanol-induced ulcers/i.p. | Rat | 200.0 mg/kg | Active [37] | |
Acid-ethanol-induced ulcers/i.p. | Rat | 400.0 mg/kg | Active [37] | |
Ethanol-induced gastric injury/intragastric | Rat | 400.0 mg/kg | Active [37] | |
Sigmoidin A
|
Stress-induced ulcers (water-immersion)/gastric intubation | Rat | 50.0 mg/kg | Active [78] |
Stress-induced (restraint) ulcers/gastric intubation | Rat | 50.0 mg/kg | Active [78] | |
Sigmoidin B
|
Stress-induced ulcers (water-immersion)/gastric intubation | Rat | 50.0 mg/kg | Active [78] |
Stress-induced (restraint) ulcers/gastric intubation | Rat | 50.0 mg/kg | Active [78] | |
Sophoranone
|
Pylorus ligation-induced ulcers/p.o. | Rat | * | Active [43] |
Stress-induced ulcers/p.o. | Rat | * | Active [43] | |
Flavane and Flavanols | ||||
(+) catechin
|
HCl/ethanol-induced stomach ulcers/intragastric | Rat | * | Inactive [79] |
*/pathway oral (p.o.) | Rat | 100.0 mg/kg | Active [80] | |
Reserpine-induced ulcers/gastric intubation | Mouse | 49.7 mg/kg | Equivocal [57] | |
Reserpine-induced ulcers/gastric intubation | Mouse | 72.5 mg/kg | Inactive [57] | |
Stress-induced ulcers (water-immersion)/gastric intubation | Mouse | 500.0 mg/kg | Weak Active [81] | |
(dl) catechin
|
Stress-induced (restraint) ulcers/subcutaneous (s.c.) | Mouse | 300.0 mg/kg | Active [82] |
Stress-induced (restraint) ulcers/intragastric | Mouse | 300.0 mg/kg | Active [82] | |
Stress-induced ulcers (water-immersion)/s.c. | Mouse | 300.0 μmol/kg | Active [82] | |
Stress-induced ulcers (water-immersion)/intragastric | Mouse | 300.0 mg/kg | Active [82] | |
3-O-methyl: (+) catechin
|
Pylorus ligation-induced ulcers/s.c. | Rat | ED50 60.0 mg/kg | Active [83] |
Stress-induced (restraint) ulcers/s.c. | Rat | ED50 13.2 mg/kg | Active [83] | |
*/s.c. | Rat | * | Active [83] | |
Phenylbutazone-induced ulcers/s.c. | Rat | * | Active [83] | |
Reserpine-induced ulcers/s.c. | Rat | * | Active [83] | |
*/* | * | * | Active [84] | |
(-) Epicatechin
|
Stress-induced ulcers (water-immersion)/gastric intubation | Mouse | 500.0 mg/kg | Weak Active [81] |
(+) Cyanidan-3-beta- ol
|
Pylorus ligation-induced ulcers/s.c. | Rat | ED50 62 mg/kg | Active [85] |
Restraint-induced ulcers/s.c. | Rat | ED50 18 mg/kg | Active [85] | |
Aspirin-induced ulcers/gastric intubation | Rat | 100.0 mg/kg | Active [85] | |
Phenylbutazone-induced ulcers/gastric intubation | Rat | 100.0 mg/kg | Active [85] | |
Ibuprofen-induced ulcers/gastric intubation | Rat | 100.0 mg/kg | Active [85] | |
Reserpine-induced ulcers/gastric intubation | Rat | 100.0 mg/kg | Active [85] | |
Leucocyanidin
|
Aspirin-induced ulcers/* | Rat | 5.0 mg/day | Active [50] |
*/intragastric | Rat | * | Active [51] | |
Flavanolols | ||||
Taxifolin
|
Ethanol induced gastric ulcers/intragastric | Rat | 50.0 mg/kg | Active [86] |
Taxifolin,(dl)
|
HCl /ethanol-induced stomach ulcers/intragastric | Rat | * mg/kg | Inactive [79] |
Anthocyanidines | ||||
Benzopyrylium chloride,1: 3,5,7- trihydroxy-2-(3-4-dihydroxyphenyl)
|
Pylorus ligation-induced ulcers/intragastric | Rat | 12.5 mg/kg | Active [87] |
Stress-induced (restraint) ulcers/intragastric | Rat | 100.0 mg/kg | Active [87] | |
Phenylbutazone-induced ulcers/intragastric | Rat | 22.0 mg/kg | Active [87] | |
Indomethacin-induced ulcers/intragastric | Rat | 100.0 mg/kg | Active [87] | |
Reserpine-induced ulcers/intragastric | Rat | 100.0 mg/kg | Active [87] | |
Ethanol induced lesion/intragastric | Rat | 200.0 mg/kg | Active [87] | |
Histamine-induced ulcers/intragastric | Rat | 24.0 mg/kg | Active [87] | |
Cysteamine-induced ulcers/intragastric | Rat | 200.0 mg/kg | Active [87] | |
Cysteamine-induced ulcers/intraperitoneal (i.p.) | Rat | 50.0 mg/kg | Active [87] | |
Acetic acid-induced ulcers/intragastric | Rat | 50.0 mg/kg | Active [87] | |
Flavones | ||||
Acacetin
|
Reserpine-induced ulcers/gastric intubation | Mouse | 0.05 mL/g | Inactive [36] |
Apigenin
|
Reserpine-induced ulcers/gastric intubation | Mouse | 0.05 mL/g | Inactive [36] |
Cynaroside
|
*/intragastric | Rat | * | * [88] |
Dactylin
|
Reserpine-induced ulcers/gastric intubation | Mouse | * | Inactive [35] |
Stress-induced (restraint) ulcers/gastric intubation | Mouse | * | Inactive [35] | |
Eupatilin
|
*/ Intragastric | Rat | * | Active [89] |
Gnaphaloside A
|
Reserpine-induced ulcers/gastric intubation | Mouse | 0.05 mL/g | Active [36] |
Gossypin
|
*/oral | Rat | 100.0 mg/kg | Active [80] |
Hyperoside
|
Reserpine-induced ulcers/gastric intubation | Mouse | * | Weak activity [35] |
Stress-induced (restraint) ulcers/gastric intubation | Mouse | * | Weak activity [35] | |
Hypolaetin-8-O-beta-d-glucoside
|
Cold stress-induced ulcers/i.p. | Rat | ED50 573mg/kg | Active [90] |
Cold stress-induced ulcers/* | * | ED50 57.3mg/kg | Active [91] | |
Ethanol-induced gastric lesions/s.c. | Rat | ED50 68.0mg/kg | Active [92] | |
Kaempferol rhamnoside
|
Reserpine-induced ulcers/gastric intubation | Mouse | 0.05 mL/g | Active [36] |
Linarin
|
Reserpine-induced ulcers/gastric intubation | Mouse | 0.05 mL/g | Inactive [36] |
Luteolin
|
*/intragastric | Rat | * | Active [88] |
Reserpine-induced ulcers/gastric intubation | Mouse | 47.4 mg/kg | Active [57] | |
Reserpine-induced ulcers/gastric intubation | Mouse | 474 mg/kg | Active [57] | |
Myricetin rhamnoside
|
Reserpine-induced ulcers/gastric intubation | Mouse | 0.05 mL/g | Active [36] |
Nobiletin
|
Ethanol-induced gastric ulcer/intragastric | Rat | ED50 8.0 mg/kg | Active [38] |
Ethanol-induced ulcers/intragastric | Rat | ED50 8.0 mg/kg | Active [93] | |
Aspirin-induced ulcers/intragastric | Rat | 50.0 mg/kg | Weak active [93] | |
HCl/ethanol-induced gastric ulcers/intragastric | Rat | 25.0 mg/kg | Active [97] | |
Pectolinarigenin
|
Reserpine-induced ulcers/gastric intubation | Mouse | 0.05 mL/g | Inactive [36] |
Pectolinarin
|
Reserpine-induced ulcers/gastric intubation | Mouse | 0.05 mL/g | Inactive [36] |
Acetyl pectolinarin
|
Reserpine-iduced ulcers/gastric itubation | Mouse | 0.05 mL/g | Inactive [36] |
Quercetin rhamnoside
|
Reserpine-induced ulcers/gastric intubation | Mouse | 0.05 mL/g | Active [36] |
Quercitrin
|
Reserpine-induced ulcers/gastric intubation | Mouse | 50.0 mg/g | Active [57] |
Robinin
|
Reserpine-induced ulcers/gastric intubation | Mouse | * | Inactive [36] |
Stress-induced (restraint) ulcers/gastric intubation | Mouse | * | Inactive [36] | |
Rutin
|
Acid-ethanol-induced ulcers/i.p. | Mouse | 12.5 mg/kg | Inactive [37] |
Acid-ethanol-induced ulcers/i.p. | Rat | 25.0 mg/kg | Active [37] | |
Acid-ethanol-induced ulcers/i.p. | Rat | 50.0 mg/kg | Active [37] | |
Pretreatment with indomethalin vs ethanol induced-ulcers/intragastric | Rat | 25.0 mg/kg | Weak activity [53] | |
Ethanol-induced ulcers/intragastric | Rat | 50.0 mg/kg | Active [53] | |
Ethanol-induced ulcers/ intragastric | Rat | 200.0 mg/kg | Active [34] | |
*/intragastric | Mouse | 7.0 mg/kg | Active [95] | |
*/intragastric | Mouse | * | Active [96] | |
Reserpine-induced ulcers/gastric intubation | Mouse | * | Weak activity [35] | |
Stress-induced (restraint) ulcers/gastric intubation | Mouse | * | Weak activity [35] | |
Salvigenin
|
Pylorus ligation-induced ulcers/i.p. | Rat | 100.0 mg/kg | Inactive [97] |
Scoparin
|
Reserpine-induced ulcers/gastric intubation | Mouse | 0.05 mL/g | Inactive [36] |
Ternatin
|
Cold stress-induced ulcers/i.p. | Rat | 25.0 mg/kg | Inactive [98] |
Ethanol-induced ulcers/i.p. | Rat | 25.0 mg/kg | Inactive [98] | |
Indomethacin-induced ulcers/i.p. | Rat | 25.0 mg/kg | Inactive [98] | |
Vexibinol
|
HCl-ethanol induced ulcers/intragastric | Rat | 10.0 mg/kg | Active [99] |
Stress-induced ulcers (water-immersion)/intragastric | Rat | 10.0 mg/kg | Active [99] | |
Pylorus ligation-induced ulcers/intragastric | Rat | 100.0 mg/kg | Active [99] | |
Indomethacin-induced ulcers/intragastric | Rat | 100.0 mg/kg | Active [99] | |
Histamine-induced ulcers/intragastric | Rat | 100.0 mg/kg | Inactive [99] | |
5-Ht-induced ulcers/intragastric | Rat | 300.0 mg/kg | Inactive [99] | |
Phenylbutazone induced ulcers/intragastric | Rat | 300.0 mg/kg | Active [99] | |
Isoflavones | ||||
Genistin
|
*/intragastric | Rat | * | Active [88] |
Flavonols | ||||
Kaempferol
|
Acid-ethanol-induced ulcers/i.p. | Rat | 250.0 mg/kg | Inactive [37] |
Acid-ethanol-induced ulcers/i.p. | Rat | 50.0 mg/kg | Active [37] | |
Acid-ethanol-induced ulcers/i.p. | Rat | 100.0 mg/kg | Active [37] | |
Ethanol-induced ulcers/i.p. | Rat | 100.0 mg/kg | Active [100] | |
Cold stress-induced ulcers/i.p. | Rat | 200.0 mg/kg | Active [100] | |
Reserpine-induced ulcers/gastric intubation | Mouse | 0.05 mL/g | Inactive [36] | |
Pylorus ligation-induced ulcers/i.p. | Rat | 200.0 mg/kg | Active [101] | |
Stress-induced (restraint) ulcers/i.p. | Rat | 200.0 mg/kg | Active [101] | |
Reserpine-induced ulcers/gastric intubation | Mouse | * | Inactive [35] | |
Stress-induced (restraint) ulcers/gastric | Mouse | * | Inactive [35] | |
Myricetin
|
Reserpine-induced ulcers/gastric intubation | Mouse | 0.05 mL/g | Inactive [36] |
Reserpine-induced ulcers/gastric intubation | Mouse | 0.05 mL/g | Active [36] | |
Reserpine-induced ulcers/gastric intubation | Mouse | * | Active [55] | |
Stress-induced (restraint) ulcers/gastric intubation | Mouse | * | Active [55] | |
Reserpine-induced ulcers/gastric intubation | Mouse | * | Active [35] | |
Stress-induced (restraint) ulcers/gastric intubation | Mouse | * | Active [35] | |
Patuletin
|
Reserpine-induced ulcers/gastric intubation | Mouse | 0.05 mL/g | Inactive [36] |
Patulitrin
|
Reserpine-induced ulcers/gastric intubation | Mouse | 0.05 mL/g | Weak active [36] |
Phellavin
|
Reserpine-induced ulcers/gastric intubation | Mouse | 0.05 mL/g | Inactive [36] |
Quercetin
|
Ethanol-induced gastric lesions/intragastric | Rat | 200.0 mg/kg | Active [59] |
Acetic acid-induced ulcers/intragastric | Rat | 100.0 mg/kg | Active [62] | |
Stress-induced ulcers (water-immersion)/intragastric | Rat | 100.0 mg/kg | Active [56] | |
Pylorus ligation-induced ulcers/intragastric | Rat | 100.0 mg/kg | Active [56] | |
Pylorus ligation-induced ulcers/intragastric | Rat | 100.0 mg/kg | Active [56] | |
*/intragastric | Rat | 200.0 mg/kg | Active [58] | |
Acid-ethanol-induced ulcers/i.p. | Rat | 12.5 mg/kg | Inactive [37] | |
Acid-ethanol-induced ulcers/i.p. | Rat | 25.0 mg/kg | Active [37] | |
Acid-ethanol-induced ulcers/i.p. | Rat | 50.0 mg/kg | Active [37] | |
Ethanol-induced gastric ulcers/i.p. | Rat | 12.5 mg/kg | Active [104] | |
*/ intragastric | Mouse | * | Active [96] | |
Ethanol-induced ulcers/intragastric | Rat | 100.0 mg/kg | Active [54] | |
Stress-induced (restraint) ulcers/intragastric | Rat | 100.0 mg/kg | Active [54] | |
Ethanol-induced ulcers/intragastric | Rat | 200.0 mg/kg | Active [60] | |
Reserpine-induced ulcers/gastric intubation | Mouse | 0.05 mL/gm | Inactive [36] | |
Reserpine-induced ulcers/gastric intubation | Mouse | 50.0 mg/kg | * [57] | |
Reserpine-induced ulcers/gastric intubation | Mouse | * | Active [55] | |
Stress-induced (restraint) ulcers/gastric | Mouse | * | Active [55] | |
Reserpine-induced ulcers/gastric intubation | Mouse | * | Active [35] | |
Stress-induced (restraint) ulcers/gastric intubation | Mouse | * | Active [35] | |
Quercetin-3'-o-beta-d-glucoside
|
Reserpine-induced ulcers/gastric intubation | Mouse | 0.05 mL/g | Inactive [36] |
Biflavonoids | ||||
Cinnamtannin B-1
|
Stress-induced ulcers (water-immersion)/gastric intubation | Mouse | 500.0 mg/kg | Inactive [81] |
Cinnamtannin D-1
|
Stress-induced ulcers (water-immersion)/gastric intubation | Mouse | 500.0 mg/kg | Inactive [81] |
Procyanidin B-1
|
Stress-induced ulcers (water-immersion)/gastric intubation | Mouse | 500.0 mg/kg | Weak activity [81] |
Procyanidin B-2
|
Stress-induced ulcers (water-immersion)/gastric intubation | Mouse | 200.0 mg/kg | Active [81] |
Procyanidin B-3
|
HCl/ethanol-induced stomach ulcers/intragastric | Rat | 200.0 mg/kg | Inactive [79] |
Procyanidin B-4
|
Stress-induced ulcers (water-immersion)/gastric intubation | Mouse | 500.0 mg/kg | Active [81] |
* Dates weren’t provided